Rocket One Inc. Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest
Rocket One Inc. (RKTO) had Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest of $11.87 million as of 2023-03-31, per its 10-Q filed 2023-05-15.
Discontinued › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest
us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest · last filed 2023-05-15
- 2023-03-31: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $11.87M.
- 2022-03-31: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $7.88M.
- 2020-09-30: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $5.38M.
- 2020-06-30: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $6.84M.
| Period end | Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest |
|---|---|
| 2023-03-31 | $11.87M 10-Q · filed 2023-05-15 |
| 2022-03-31 | $7.88M 10-Q · filed 2023-05-15 |
| 2020-09-30 | $5.38M 10-Q · filed 2020-11-10 |
| 2020-06-30 | $6.84M 10-Q · filed 2020-11-10 |
| 2019-12-31 | $2.40M 10-Q · filed 2020-11-10 |
| 2019-09-30 | $4.31M 10-Q · filed 2020-11-10 |
| 2019-06-30 | $4.19M 10-Q · filed 2020-11-10 |
| 2018-12-31 | $154.97K 10-Q · filed 2020-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |